The PP31J can inhibit the NF-κB pathway by reducing the phosphorylation level of IκBα (Xu et al., 2014), increase the level of ROS in tumor cells, cause cycle arrest (Ding et al., 2014) and inhibit cell proliferation. This evidence concerns the gene NFKB1 and neoplasm.